The clinical research group KFO 296 at the University Hospital Hamburg-Eppendorf (UKE) is to receive funds of EUR 3.7 million until 2021 from the German Research Foundation (DFG), a press release said Friday (August 3, 2018). The first funding phase focused on pregnant women and the second phase will be dedicated to children’s health. In the initial funding phase, the DFG had “supported” the UKE research group with EUR 3.4 million euros since 2015:https:https://www.hamburg-news.hamburg/en/health-life-sciences/uke-get-more-funds/. The researchers had received start-up funding from Hamburg’s former Ministry of Science and Research since 2011.
“We want to lower the risk of serious infections for pregnant women and their unborn children. We want to develop guidelines for identifying unborn or newborn children with a high risk of immune diseases in later life to reduce the risk for these children as early as possible,” said Prof. Dr. Petra Arck, Department of Obstetrics and Prenatal Medicine. Additional project managers have been integrated into KFO 296 including doctors from other departments. “In addition to strengthening the paediatric focus, methods such as single cell sequencing, systems biology and virological approaches are also represented in our questions,” said Arck.
Mix of laboratories and hospitals
The research group comprises physicians and basic researchers from various clinics and institutes at UKE and the Heinrich Pette Institute. Collaborations with the Robert Koch Institute in Berlin, the Leids Universitair Medisch Centrum in Leiden (Netherlands), the University of Glasgow in Britain and Jinan University in Guangzhou also exist.
Sources and further information: